Readthrough to Viking Therapeutic (VKTX) from Ligand (LGND) Short Report is 'Ridiculous' - Raymond James

January 17, 2019 7:35 AM
Raymond James analyst Steve Seedhouse said the read-through to Viking Therapeutic (NASDAQ: VKTX) from Citron Research's short report on Ligand ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Analyst Comments Hot Comments Short Sales Trader Talk